Nexalin Technology, Inc. (NXL)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
No Form 4 activity for NXL in the last 90 days.
17 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark White - Officer | Grant or award | Stock Option (right to buy)* | 1,000,000 | $0.00 | - | |
| Fleet Justin van - Officer | Grant or award | Stock Option (right to buy)* | 100,000 | $0.00 | - | |
| David Owens - Officer | Grant or award | Stock Option (right to buy)* | 1,000,000 | $0.00 | - | |
| Carolyn Hamby Shelton - Officer | Grant or award | Stock Option (right to buy)* | 100,000 | $0.00 | - | |
| Ben Hu - Director | Grant or award | Stock Option (right to buy)* | 100,000 | $0.00 | - | |
| Alan Kazden - Director | Grant or award | Stock Option (right to buy)* | 100,000 | $0.00 | - | |
| Ben Hu - Director | Grant or award | Common stock | 36,459 | $0.00 | - | |
| Alan Kazden - Director | Grant or award | Common stock | 36,459 | $0.00 | - | |
| David Owens - Officer | Grant or award | Common stock | 36,459 | $0.00 | - | |
| Leonard Osser - 10% Owner | Grant or award | Common Stock | 83,333 | $0.00 | - | |
| David Owens - Officer | Grant or award | Stock Option (right to buy) | 203,125 | $0.00 | - | |
| David Owens - Officer | Grant or award | Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Carolyn Hamby Shelton - Officer | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Open-market sale | Common Stock Warrants | 23,150 | $0.52 | $403 | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| David Owens - Officer | Open-market purchase | Common stock | 500 | $65.70 | $1K | |
| Ben Hu - Director | Grant or award | Common stock | 175,000 | $0.00 | - | |
 Leslie Bernhard - Director | Grant or award | Common stock | 49,838 | $0.00 | - |
Nexalin Technology, Inc. (NXL) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-12-23. The full record for NXL runs to 17 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of NXL were filed in the last 90 days. 1 purchase is on record for this company.
No insider sales of NXL were filed in the last 90 days. 1 sale is on record for this company.
This page tracks NXL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NXL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
